July 15, 2022
Via: PharmaphorumThe PureTech group company – which scored the first FDA and EMA approvals for a DTx for attention-deficit hyperactivity disorder (ADHD) – is developing AKL-T01 to tackle cognitive impairments that can affect people with SLE. Cognitive dysfunction occurs in between […]
July 19, 2024
July 11, 2024
July 11, 2024